Celularity (CELUW) Change in Accured Expenses (2019 - 2025)

Celularity (CELUW) has 7 years of Change in Accured Expenses data on file, last reported at $3.7 million in Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $3.7 million, down 31.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $13.5 million (up 6.47% YoY), and the FY2025 annual result was $13.5 million, up 6.47% from the prior year.
• Change in Accured Expenses grew to $3.7 million in Q4 2025 per CELUW's latest filing, from $822000.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $6.2 million in Q2 2025 and troughed at -$9.2 million in Q4 2022.
• A 5-year average of $1.0 million and a median of $1.0 million in 2023 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 13765.96% in 2021 and fell as far as 785.75% in 2021.
• A 5-year view of Change in Accured Expenses shows it stood at -$5.6 million in 2021, then tumbled by 62.37% to -$9.2 million in 2022, then soared by 70.98% to -$2.7 million in 2023, then surged by 302.82% to $5.4 million in 2024, then slumped by 31.54% to $3.7 million in 2025.
• Business Quant data shows CELUW's Change in Accured Expenses at $3.7 million in Q4 2025, $822000.0 in Q3 2025, and $6.2 million in Q2 2025.